Related Experiment Video
Updated: Sep 27, 2025

11:34
A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
Published on: May 10, 2022
2.3K
Adolescents with chronic hepatitis C might be good candidates for direct-acting antiviral therapy
Ken Sato1,2, Yuichi Yamazaki1, Yuki Kanayama1
1Department of Gastroenterology and Hepatology Gunma University Graduate School of Medicine Gunma Japan.
Clinical Case Reports
|April 13, 2022
Abstract:
Three Japanese adolescents with chronic hepatitis C were treated by direct-acting antivirals (DAAs). No adverse events or laboratory abnormalities were observed during and after DAA therapy, and a sustained virological response was achieved in all cases. The emotional functioning of the patients and their mothers were improved after DAA therapy.

